Resultados de la búsqueda 701-710 of 19104 for Two-phase

  1. Oncología (médica) - Ensayos clínicos

    ... two cycles of mosunetuzumab. An additional arm ... MC1733, Phase I Trial of Intratumoral ... Phase I/​II Study of [225Ac]Ac-PSMA-R2 in PSMA ...

  2. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    The purpose of this study is to evaluate the safety and tolerability and determine the recommended Phase 2 dose (RP2D) of YH001 when given with envafolimab ...

  3. Las etapas del trabajo de parto y el parto: ¡llegó el momento de tener al bebé! - Mayo Clinic

    Etapa 2: el nacimiento de tu bebé. ¡Ya es la hora ... Labor: Diagnosis and management of the latent phase. ... Stages of labor and birth Baby its time. Tu ...

  4. Neurología - Ensayos clínicos - Mayo Clinic

    ... stage glioma tumors and evaluate response to therapy. ... This randomized phase III trial compares ... 2-year progression free survival (PFS) rate as compared to ...

  5. Oncología (médica) - Ensayos clínicos

    The purpose of this study is to evaluate the safety and tolerability and determine the recommended Phase 2 dose (RP2D) of YH001 when given with envafolimab ...

  6. Oncología (médica) - Ensayos clínicos

    The purpose of this study is to evaluate the safety and tolerability and determine the recommended Phase 2 dose (RP2D) of YH001 when given with envafolimab ...

  7. Oncología (médica) - Ensayos clínicos

    This randomized phase II trial studies how well olaparib, cediranib maleate ... This is a randomized Phase 2 study of novel SEQUEnced immunotherapy ...

  8. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    Rochester, Minn. The purpose of this study is to evaluate how well combination chemotherapy works in treating patients with newly diagnosed stage II-IV diffuse ...

  9. Oncología (médica) - Ensayos clínicos

    The purpose of this study is to evaluate the safety and tolerability and determine the recommended Phase 2 dose (RP2D) of YH001 when given with envafolimab ...

  10. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    This phase II trials studies how well acalabrutinib with or without obinutuzumab works in treating participants with early-stage chronic lymphocytic leukemia or ...